Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer (BC). Due to the absence of targets such as HER2 or hormone receptors, early TNBC is treated with surgery and chemotherapy. Since TNBC is also considered the most immunogenic type of BC with tumor infiltrat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Massa, Chiara, Karn, Thomas, Denkert, Carsten, Schneeweiss, Andreas, Hanusch, Claus, Blohmer, Jens-Uwe, Zahm, Dirk-Michael, Jackisch, Christian, van Mackelenbergh, Marion, Thomalla, Jörg, Marme, Frederik, Huober, Jens, Müller, Volkmar, Schem, Christian, Mueller, Anja, Stickeler, Elmar, Biehl, Katharina, Fasching, Peter A, Untch, Michael, Loibl, Sibylle, Weber, Karsten, Seliger, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7670944/
https://ncbi.nlm.nih.gov/pubmed/33199511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados